Comprehensive Overview of Sitagliptin for the Pharmacist: Clinical Insights and Evidence-Based Guidance
1. Introduction to Sitagliptin Sitagliptin is a DPP-4 (dipeptidyl peptidase-4) inhibitor, marketed under the brand name Januvia® (and as Janumet® in combination with metformin). It is a cornerstone therapy in the management of type 2 diabetes mellitus (T2DM). As a prescription-only medication, it requires careful consideration by pharmacists to ensure safe and effective use. 2….